FDA Approves Pfizer-BioNTech’s COVID-19 Vaccine
The first vaccine for COVID-19 was approved by the FDA on Aug 23, 2021. The Pfizer-BioNTech vaccine will now be marketed as Comirnaty for those aged 16 and older. For those aged 12-15 years as well as immunocompromised individuals needing a third dose, the vaccine is still available under emergency use authorization (EUA).
Click here to read the full FDA press release.